TP53 and acute lymphoblastic leukemia: Analysis of the RNA-seq data revealed molecular abnormalities in six patients and reversed molecular abnormalities in three (CREBBP, TP53, and P2RY-CRLF2), as well as previously unreported genetic mutations in B-ALL (Zou et al., 2022).